Rare diseases
Investigational molecules
Locations
Via Filippo Corridoni 11, 60123 Ancona, Italy
Azienda Ospedaliero Universitaria Ospedali Riuniti Umberto I G M Lancisi G Salesi in Ancona, Italy specialises in clinical trials of conditions such as Acute myeloid leukaemia, Colorectal cancer metastatic, Plasma cell myeloma, Acute lymphocytic leukaemia, and other specialisations. This site conducts important research.
The medical center is at the forefront of research in gastroenterology, focusing on innovative treatments for ulcerative colitis in pediatric populations. The center's work aims to enhance the induction of remission and maintain therapeutic effects in children and teenagers.
Through cutting-edge clinical trials, the center is pioneering new approaches to manage and treat chronic gastrointestinal conditions in younger patients.
Specializing in hematology and oncology, the center conducts extensive research on Langerhans Cell Histiocytosis and Acute Myeloid Leukemia. The focus is on reducing mortality and improving treatment outcomes through novel therapeutic strategies.
The center's research contributes significantly to the development of personalized medicine approaches, enhancing patient survival and quality of life.
In the field of immunology, the center is advancing the understanding and treatment of neutropenias and septic shock. Research efforts are directed towards improving infection management and reducing mortality through innovative therapies.
By exploring new therapeutic avenues, the center aims to enhance immune system function and patient outcomes in severe infectious conditions.
The center is a leader in respiratory medicine, focusing on idiopathic pulmonary fibrosis. Research is dedicated to evaluating new treatments that improve lung function and patient quality of life.
Through rigorous clinical trials, the center is paving the way for more effective management of chronic respiratory diseases.
In the realm of neurology, the center is exploring treatments for hypoxic-ischemic encephalopathy in newborns. The research focuses on reducing neurodevelopmental impairments through innovative therapeutic interventions.
The center's work is crucial in developing strategies to improve neurological outcomes in affected infants.
Clinical trials currently enrolling participants at this site.
A Study of Baricitinib to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes
ItalyA Study of Baricitinib to Delay Type 1 Diabetes in Children and Adults at Risk of Developing the Disease
ItalyPhase 3 Study of Oral Orforglipron vs Weekly Dulaglutide in Children and Adolescents (10‑<18 years) with Type 2 Diabetes
ItalyStudy of chemotherapy with blinatumomab and tyrosine kinase inhibitors in newly diagnosed children and young adults with Philadelphia chromosome positive B-cell acute lymphoblastic leukemia
ItalyStudy on Cetuximab and Drug Combination for Patients with Metastatic Colorectal Cancer
ItalyStudy of Faricimab Treatment Given Every 24 Weeks in Patients with Age-Related Macular Degeneration
ItalyStudy of gemtuzumab ozogamicin with chemotherapy for adults aged 18-60 with newly diagnosed favorable-intermediate-risk acute myeloid leukemia
ItalyStudy on Avelumab and Cetuximab for Patients with Metastatic Colorectal Cancer Who Have Previously Received Treatment
ItalyStudy of Vemurafenib and Rituximab for Untreated Hairy Cell Leukemia Patients
ItalyStudy Comparing Atezolizumab Alone and Atezolizumab with Bevacizumab for First-Line Treatment in Patients with Advanced Non-Small-Cell Lung Cancer
ItalyStudy of Nivolumab for Early Stage Hodgkin Lymphoma in Patients with Good Prognosis
ItalyStudy of Azacitidine and Drug Combination Before Stem Cell Transplantation in Patients with High-Risk Myelodysplastic Syndrome
ItalyMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
